- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 15, 2026 | 5.85M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 5.03M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 401.96K sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$2.42M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$2.53M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.09M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $334.01K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $3.35M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $2.25M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $3.29M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $709.15K |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $8.31M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $7.97M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $8.46M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $8.22M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $2.46M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $502.91K |
| Total Assets | Q1 2026 · Mar 31, 2026 | $11.81M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $10.48M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.43 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$7.60 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.43 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$7.60 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.16M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $596.89K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $267.24K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $1.57M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$2.15M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$3.05M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$2.22M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$2.95M |